NPPA approves prices of 25 new drugs including Dapagliflozin, Metformin, Details Medical Dialogues Team7 Aug 2021 4:48 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) approved retail pricing for 25 new drugs under the Drug Price Control Order...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Lupin Medical Dialogues Team29 July 2021 6:21 PM ISTNew Delhi: With the popular antidiabetic drug, Dapagliflozin, going off-patent, the National Pharmaceutical Pricing Authority (NPPA) panel, giving...
Setback to AstraZeneca: Delhi HC rejects plea against 9 pharma firms over Dapagliflozin Medical Dialogues Team26 July 2021 4:12 PM ISTNew Delhi: In a major setback to AstraZeneca and its Indian subsidiary ,the Delhi High Court has dismissed AstraZeneca's plea against nine generic...
SGLT2 inhibitor dapagliflozin safe and effective in patients with advanced kidney disease: Study Hina Zahid21 July 2021 6:15 PM ISTThe effects of dapagliflozin in patients with stage 4 CKD are similar to effects in patients with mild to moderate CKD. USA: The benefits of...
NPPA fixes price of 14 formulations including Diabetes drugs and antibiotics, Details Medical Dialogues Team20 July 2021 1:31 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Glenmark gets CDSCO panel marketing nod to Remogliflozin, Teneligliptin FDC Medical Dialogues Team18 July 2021 11:30 AM ISTNew Delhi: In a major rejoice to Mumbai-based Glenmark Pharmaceuticals Limited, the Subject Expert Committee (SEC) of the Central Drugs Standard...
Dapagliflozin reduces risk of new type 2 diabetes in CKD patients: Study Medha Baranwal30 Jun 2021 9:00 AM ISTDelhi: Treatment with dapagliflozin in chronic kidney disease (CKD) patients significantly reduced the risk of new-onset type 2 diabetes (T2D), show...
Mankind Pharma launches Dapagliflozin brand Justoza for diabetes, heart failure, CKD Ruchika Sharma23 Jun 2021 1:30 PM ISTNew Delhi: Mankind Pharma has launched Justoza, a Dapagliflozin brand marketed by Mankind to treat Diabetes, Heart Failure and Chronic...
Adjuvant Therapy with Dapagliflozin bests Insulin Dose Escalation in Diabetes: Study MD Bureau15 Jun 2021 9:00 AM ISTNearly 1 in 4 patients with type 2 diabetes mellitus eventually require insulin therapy because of progressive deterioration of glycemic control. A...
Dapagliflozin improves kidney and cardiac function in cases of FSGS kidney disease: Study Hina Zahid10 Jun 2021 9:00 AM ISTSGLT2 inhibitors offer a promising new therapeutic option in the field of nephrology and are likely to be used more extensively in future, both in...
SGLT2 inhibitors improve biomarkers indicative of CVD risk in diabetes patients: Study Medha Baranwal2 Jun 2021 9:30 AM ISTTurkey: Both dapagliflozin and empagliflozin significantly improve plasma atherogenic biomarkers (AIP and TyG indexes), an indicator of cardiovascular...
Abbott, AstraZeneca terminate agreement for diabetes drug Dapagliflozin in India Ruchika Sharma30 May 2021 10:15 AM ISTNew Delhi: Drug major AstraZeneca Pharma India on Friday said it has terminated its distribution agreements with Abbott Healthcare for type 2 diabetes...
